" class="no-js "lang="en-US"> Therapeutics Archives - Medtech Alert
Wednesday, April 17, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease

The University of Oxford and Selvita, one of the largest contract research organizations in Europe, […]

Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements […]

PTP Announces Partnership with TetraScience to Accelerate Innovation in Therapeutics

PTP, a leading cloud consultancy firm specializing in the life sciences industry, is pleased to […]

BioAge Labs to Present on Therapeutics for Brain Aging Targeting NLRP3, Apelin, and Other Novel Pathways

BioAge Labs, a privately held clinical-stage biotechnology company developing therapeutics that target the molecular causes […]

Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio

Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and […]

Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today […]

Ryne Biotechnology Awarded $4 Million from the California Institute for Regenerative Medicine

Ryne Biotechnology, a therapeutics company leveraging induced pluripotent stem cell (iPSC) technology to discover and […]

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

AbbVie and Immunome,  a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more